Inactivation of gram-positive bacteria
US-9039966-B2 · May 26, 2015 · US
US9937274B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9937274-B2 |
| Application number | US-201615065894-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 10, 2016 |
| Priority date | Mar 18, 2015 |
| Publication date | Apr 10, 2018 |
| Grant date | Apr 10, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A lighting system includes a light source configured to generate light toward one or more surfaces or materials to inactivate one or more pathogens on the one or more surfaces or materials. The light includes an inactivating portion having wavelengths in a range of 280 to 380 nanometers.
Opening claim text (preview).
What is claimed is: 1. A system comprising: a light source configured to generate light toward one or more surfaces or materials to inactivate one or more pathogens on the one or more surfaces or materials in an environment for human occupancy, the light including an inactivating portion having peak wavelength in a range of greater than 300 nanometers to below 380 nanometers. 2. The system of claim 1 , wherein the one or more pathogens that are inactivated by at least the inactivating portion of the light includes one or more of staphylococcus, clostridium, or streptococcus. 3. The system of claim 1 , wherein the light source is configured to generate the light toward the one or more surfaces or materials while also concurrently exposing one or more human beings to the light. 4. The system of claim 1 , wherein the light source is configured to generate the light toward the one or more surfaces or materials to inactivate the one or more pathogens without using a photosensitizer. 5. The system of claim 1 , wherein the light source is configured to generate the light so that the inactivating portion of the light is imperceptible to a human observer of the light. 6. The system of claim 1 , wherein the light source is configured to generate the inactivating portion of the light such that the inactivating portion of the light includes no more than 0.00015 watts of actinic ultraviolet light per square meter of floor area. 7. The system of claim 1 , wherein the light source is configured to generate the inactivating portion of the light such that the inactivating portion of the light includes no more than 0.5 watts per square meter of floor area of ultraviolet A light. 8. The system of claim 1 , wherein the light source is configured to generate no more than 11 watts of blue light per steradian per square meter. 9. The system of claim 1 , wherein the light source is configured to generate the inactivating portion of the light such that the inactivating portion of the light includes no more than 0.001 watts of actinic ultraviolet light per square meter of floor area. 10. The system of claim 1 , wherein the light source is configured to generate the inactivating portion of the light such that the inactivating portion of the light includes no more than 10 watts of ultraviolet A light per square meter of floor area. 11. The system of claim 1 , wherein the light source is configured to generate no more than 100 watts of blue light per steradian per square meter. 12. The system of claim 1 , wherein the light source is configured to generate the inactivating portion of the light such that the inactivating portion of the light includes no more than 0.003 watts of actinic ultraviolet light per square meter of floor area. 13. The system of claim 1 , wherein the light source is configured to generate the inactivating portion of the light such that the inactivating portion of the light includes no more than 33 watts of ultraviolet A light per square meter of floor area. 14. The system of claim 1 , wherein the light source is configured to generate no more than 10,000 watts of blue light per steradian per square meter. 15. The system of claim 1 , wherein the light source is configured to generate the light such that the inactivating portion of the light includes wavelengths in a range of 320 to 380 nm. 16. The system of claim 1 , wherein the light source is configured to generate the light such that the inactivating portion of the light has a peak wavelength in a range of 320 to 370 nm. 17. The system of claim 1 , wherein the light source is configured to generate the light such that the inactivating portion of the light is pulsed at a frequency exceeding 100 hertz with a duty factor of less than 0.5. 18. The system of claim 1 , wherein the light source is configured to generate the light such that the inactivating portion of the light is pulsed at a frequency exceeding 100 hertz with a duty factor of less than 0.1. 19. The system of claim 1 , wherein the light source generates the light to include the inactivating portion of the light with wavelengths in a range of 280 to 380 nanometers, and a second portion of the light having longer wavelengths. 20. A method comprising: generating light from a light source toward one or more surfaces or materials to inactivate one or more pathogens on the one or more surfaces or materials in an environment for human occupancy, the light generated at a power density of no more than five watts per square meter at an exposed area of the one or more surfaces or materials with an inactivating portion of the light including peak wavelengths in a range of greater than 300 nanometers to below 380 nanometers. 21. The method of claim 20 , wherein the one or more pathogens that are inactivated by at least the inactivating portion of the light includes one or more of staphylococcus, clostridium difficile, or streptococcus. 22. The method of claim 20 , wherein the light source is configured to generate the light toward the one or more surfaces or materials while also concurrently exposing one or more human beings to the light. 23. A system comprising: a light source configured to generate light toward one or more surfaces or materials to inactivate one or more pathogens on the one or more surfaces or materials in an environment for human occupancy, the light including an inactivating portion having wavelengths in a range of 280 to below 380 nanometers, wherein the light source is configured to generate the light such that the inactivating portion of the light has peak wavelength in a range of 320 to 370 nm. 24. The system of claim 23 , wherein the light source is configured to generate no more than 100 watts of blue light per steradian per square meter. 25. The system of claim 23 , wherein the light source is configured to generate the light so that the inactivating portion of the light is imperceptible to a human observer of the light.
Room floors or walls · CPC title
Apparatus for generating biocidal substances, e.g. vaporisers, UV lamps · CPC title
Human Necessities · mapped topic
Ultraviolet [UV] radiation · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.